Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
A live webcast and archived replay of the Company's presentation can be accessed under "Events and Presentations" in the Investor & Media Relations section of the Zenas BioPharma website. About Zenas ...
MCLEAN, Va., Jan. 28, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Mission Technologies division was ...
LPL Solar LLC is proud to announce the promotion of James Plumley to Vice President of Engineering. With over 30 years of ...
Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader ...
Nigerian music stars Slimcase and Burna Boy are trending on social media over their recent interaction. A video made the rounds showing the moment the ...
Nigerian singer Oluwafemi Oladapo, popularly known as Slimcase, is facing backlash on social media after a video surfaced ...
Pulse Nigeria on MSN8d
Slimcase faces backlash for bowing to greet Burna Boy in viral videoNigerian singer Oluwafemi Oladapo, popularly known as Slimcase, is facing backlash on social media after a video surfaced ...
8d
AnaptysBio, Inc. ANAB declined 12.3% to $14.81 in pre-market trading after gaining over 6% on Tuesday. Marine Products ...
A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...
In the tough market conditions last year, investors and big pharma companies were more likely to place their bets on later, clinical-stage companies. But local biotech leaders see signs of change in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback